Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
To explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer.
Condition or disease
Non-adherence to oral medications is a prevalent problem in adolescents and young adults (AYA) with cancer that may impact both survival and quality of life while on treatment. The purpose of this study is to explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer. The study's primary aim is to explore the feasibility and acceptability of using a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer as well as to characterize application use. Secondary aims include: 1) to obtain initial estimates of intervention effect- measured by pre-intervention to post-intervention differences in perceived behavioral control for adherence, intention to adhere, and adherence behavior - to inform design of a future trial powered to detect a clinically significant effect of smart-phone medication reminder application use on adherence to oral medications; and 2) to examine the relationships among perceived behavioral control for adherence, intention to adhere, and adherence behavior. A pre-post single group design will be used. Data will be collected weekly for 4 weeks before introduction of the intervention and for 8 weeks following introduction of the intervention. Analytic approaches will include descriptive statistics and generalized estimating equation (GEE) modeling.
Feasibility and Acceptability of Using a Smart-phone Medication Reminder Application to Promote Adherence to Oral Medications by AYA With Cancer. [ Time Frame: ongoing study weeks 5-12 ]
Feasibility was assessed through participants' application usage and responses to self-reported questions about their use of the application. Acceptability was assessed through participants' perceived ease of use and perceived usefulness of the application.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
15 Years to 29 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Primary care clinics for patients be treated for cancer.
1)15-29 year olds receiving treatment for any type of cancer, either primary or recurrent/relapsed disease.
2) Patient has completed at least one month of therapy
3)Patient is expected to remain on therapy for 3 month duration of study
4) Patient has an iPhone, iPad, or iTouch running iOS 4.0 or later
5) Patient is willing to use a smart-phone medication reminder application-
1)Patients who are unable to speak/read/write English as required for use of smart-phone medication reminder application and completion of study measures.